Abstract 1569: Treatment of PAX3-FOXO1 alveolar rhabdomyosarcoma with ICP34.5-armed G47Δ oncolytic herpes simplex virus confers survival benefit when co-administered with anti-Pd1 antibody
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: University of California, Los Angeles
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148863245
Cites:
Cited by:
Related to:
